Get started
Work

Supplementary Table S2 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group

Year: 2024
Type: supplementary-materials
Abstract: Qualitative and Quantitative Summary of Abnormal Peripheral Blood and Bone Marrow Findings.
DOI: 10.1158/2159-8290.26935122.v1
Authors: Elliot Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis, Donald A. Barkauskas, David Hall, Scott C. Kogan, Julia Meyer, Steven D. Rhodes, Sarah K. Tasian, Xiaoling Xuei, Kevin Shannon, Mignon L. Loh, Elizabeth Fox, Brenda J. Weigel
Language: English
Open Access status: gold
OpenAlex ID: W4402224527
Cites:
Cited by:
Related to: 10